Literature DB >> 18716425

Functional impairment in patients with remitted bipolar disorder.

A R Rosa, C Franco, A Martínez-Aran, J Sánchez-Moreno, M Reinares, M Salamero, C Arango, J L Ayuso-Mateos, F Kapczinski, E Vieta.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18716425     DOI： 10.1159/000151520

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN： 0033-3190            Impact factor:   17.659


× No keyword cloud information.
  12 in total

Review 1.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

2.  TSPO upregulation in bipolar disorder and concomitant downregulation of mitophagic proteins and NLRP3 inflammasome activation.

Authors:  Giselli Scaini; Tatiana Barichello; Gabriel R Fries; Elizabeth A Kennon; Taylor Andrews; Bobby R Nix; Giovana Zunta-Soares; Samira S Valvassori; Jair C Soares; João Quevedo
Journal:  Neuropsychopharmacology       Date:  2018-12-11       Impact factor: 7.853

Review 3.  Treatment of Functional Impairment in Patients with Bipolar Disorder.

Authors:  Jose Sanchez-Moreno; Anabel Martinez-Aran; Eduard Vieta
Journal:  Curr Psychiatry Rep       Date:  2017-01       Impact factor: 5.285

Review 4.  A systematic review of psychosocial functioning and quality of life in older people with bipolar disorder.

Authors:  Dr Elizabeth Tyler; Professor Fiona Lobban; Mr Bogdan Hadarag; Professor Steven Jones
Journal:  J Affect Disord Rep       Date:  2022-07

5.  The noradrenaline metabolite MHPG is a candidate biomarker between the depressive, remission, and manic states in bipolar disorder I: two long-term naturalistic case reports.

Authors:  Masatake Kurita; Satoshi Nishino; Yukio Numata; Yoshiro Okubo; Tadahiro Sato
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-11       Impact factor: 2.570

6.  Bipolar disorder and socioeconomic status: what is the nature of this relationship?

Authors:  Laeticia Eid; Katrina Heim; Sarah Doucette; Shannon McCloskey; Anne Duffy; Paul Grof
Journal:  Int J Bipolar Disord       Date:  2013-06-21

Review 7.  Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode.

Authors:  Masatake Kurita
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-20       Impact factor: 2.570

8.  The Relationship between Impulsivity and Quality of Life in Euthymic Patients with Bipolar Disorder.

Authors:  Yoon-Seok Kim; Boseok Cha; Dongyun Lee; Sun-Mi Kim; Eunsoo Moon; Chul-Soo Park; Bong-Jo Kim; Cheol-Soon Lee; Sojin Lee
Journal:  Psychiatry Investig       Date:  2013-09-16       Impact factor: 2.505

9.  The noradrenaline metabolite MHPG is a candidate biomarker from the manic to the remission state in bipolar disorder I: a clinical naturalistic study.

Authors:  Masatake Kurita; Satoshi Nishino; Yukio Numata; Yoshiro Okubo; Tadahiro Sato
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

10.  Psychometric properties and validation of a four-item version of the Strauss-Carpenter scale in bipolar disorder.

Authors:  Susana Alberich; Sara Barbeito; Itxaso González-Ortega; Amaia Ugarte; Patricia Vega; Sonia Ruiz de Azúa; Purificación López; Iñaki Zorrilla; Ana González-Pinto
Journal:  Int J Bipolar Disord       Date:  2016-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.